CarmelBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnology Research
Description
Sudo Biosciences has announced the appointment of Paul S. Bavier, J.D., as Chief Legal Officer. He brings over two decades of legal experience in the biotechnology industry and will contribute to the company's strategic and operational growth.
Who to call at Sudo Biosciences, and when
A new leader at Sudo Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Sudo Biosciences raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Sudo Biosciences, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Sudo Biosciences
Location
Carmel, Indiana, United States
About
Sudo Biosciences is a clinical-stage biopharmaceutical company developing next-generation TYK2 inhibitors to transform the treatment of immune-mediated diseases. Its pipeline includes a potential first- and best-in-class, once-daily oral, brain-penetrant candidate for multiple sclerosis and other neuroinflammatory conditions, as well as a topical candidate for dermatologic diseases. Based in Carmel, IN and London, U.K., Sudo is advancing novel medicines designed to improve patient lives.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sudo Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CarmelBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnology Research